NCT05674136已完成不适用
Clinical Equivalence of Masimo INVSENSOR00061 to RD SET Neo
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 2
- 主要终点
- SpO2 Accuracy
研究概览
简要总结
This study is designed to compare the equivalence of the Masimo INVSENSOR00061 to RD SET Neo for SpO2 and performance of PR and RRp as the subjects undergo a controlled desaturation protocol. This type of study design is required to evaluate the performance of pulse oximeters based upon the ISO 80601-2-61 standard which is also adopted and referenced by the FDA.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subject is 18 to 50 years of age.
- •Subject weighs a minimum of 110 lbs.
- •Hemoglobin value ≥ 11 g/dL.
- •Baseline heart rate ≥ 45 bpm and ≤ 85 bpm.
- •Blood Pressure: Systolic BP ≤ 140 mmHg and ≥ 90 mmHg, Diastolic BP ≤ 90 mmHg and ≥ 50 mmHg, and if systolic BP is lower than 100 mmHg and/or diastolic BP is lower than 60 mmHg, subject passes an orthostatic blood pressure test.
- •CO value ≤ 3.0% FCOHb.
- •Subject is able to read and communicate in English and understands the study and the risks involved
排除标准
- •Subject is pregnant.
- •Subject has a BMI >
- •Subject is wearing nail polish that cannot be removed, gel nails, and/or acrylic nails that can interfere with study device's placement is deemed ineligible at the discretion of investigator/study staff. *
- •Subject has a history of fainting (vasovagal syncope), blacking out or losing consciousness during or after a blood draw, or has a fear of blood draws.
- •Subject has open wounds, inflamed tattoos or piercings, and/or has any visible healing wounds that a medical professional determines may place them at an increased risk for participation. *
- •Subject has known drug or alcohol abuse.
- •Subject uses recreational drugs. *
- •Subject experiences frequent or severe headaches and/or migraine headaches, migraine auras, altitude sickness, and/or headaches accompanied by visual changes or sensitivity to light or sound.
- •Subject has experienced a concussion or head injury with loss of consciousness within the past 12 months.
- •Subject has any history of a stroke, myocardial infarction (heart attack), and/or seizures.
- •Subject has any chronic bleeding disorder (e.g., hemophilia).
- •Subject has taken anticoagulant medication within the past 30 days (excluding nonsteroidal anti-inflammatory drugs (NSAIDS)).
- •Subject has donated blood within the past 4 weeks.
- •Subject has Wolff-Parkinson-White Syndrome or Stokes-Adams Syndrome.
- •Subject has any cardiac dysrhythmia (e.g., atrial fibrillation) and has not received clearance from their physician to participate.
- •Subject has a known neurological and/or psychiatric disorder (e.g., schizophrenia, bipolar disorder, Multiple Sclerosis, Huntington's disease) that interferes with the subject's level of consciousness. *
- •Subject has taken opioid pain medication 24 hours before the study.
- •Subject has any active signs and/or symptoms of infectious disease (e.g., Hepatitis, HIV, Tuberculosis, Flu, Malaria, Measles, etc.). *
- •Subject is taking medications known to treat any type of infectious disease.
- •Subject has either signs or history of peripheral ischemia or carpal tunnel syndrome.
- •Subject has had invasive surgery within the past year, including but not limited to major dental surgery, appendectomy, plastic surgery, jaw surgery, major ENT surgery, major abdominal and/or pelvic surgery, heart surgery, or thoracic surgery. *
- •Subject has symptoms of congestion, head cold, or other illnesses.
- •Subject has been in a severe car accident(s) or a similar type of accident(s) requiring hospitalization within the past 12 months.
- •Subject has any cancer or history of cancer (not including skin cancer). *
- •Subject has chronic unresolved asthma, lung disease (including COPD) and/or respiratory disease.
- •Subject is allergic to lidocaine, chlorhexidine, latex, adhesives, or plastic.
- •Subject has a heart condition, insulin-dependent diabetes, or uncontrolled hypertension.
- •Subject has delivered vaginally, has had a pregnancy terminated, a miscarriage with hospitalization or had a C-section within the past 6 months.
- •Subject intends on participating in any heavy lifting, repetitive movement of their wrist (including riding a motorcycle, tennis), exercise (working out, riding a bike, riding a skateboard, etc.), or any activity that will put additional stress on the wrist within 24 hours following a study that involves an arterial line.
- •Subject has any medical condition which in the judgment of the investigator and/or medical staff, renders them ineligible for participation in this study or subject is deemed ineligible by the discretion of the investigator/study staff.
- •(*)Physician's discretion.
结局指标
主要结局
SpO2 Accuracy
时间窗: 1-3 hours
SpO2 accuracy was determined by calculating the root mean-squared (rms) difference between the measured values (SpO2i) to the reference values (SpO2ref\_i) in accordance with ISO-80601-2-61. Arms= √(∑(i=1 to n) ((SpO2\_i-SpO2ref\_i )\^2 ))/n
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile SubejctsFeverNCT05787782Masimo Corporation60
招募中
2 期
A comparative study to evaluate the effect of vrishamuladi oil based enema and decoction based enema in the management of sciaticaCTRI/2023/10/058266Sri Venkateswara Ayurvedic college and Hospital
已完成
不适用
Prospective clinical comparisons of semitendinosus versus semitendinosus and gracilis tendon autografts for anatomic double-bundle anterior cruciate ligament reconstruction.JPRN-UMIN000017451Hokkaido University Graduate School of Medicine120
尚未招募
不适用
A study to compare the effects between Sahachar tail matra basti with and without churna and saindhav in the management of Lower back acheCTRI/2018/09/015731PDEAs college of ayurved and research center
已完成
3 期
Oral versus vaginal progesterone for treatment of endometrial hypreplasiaEndometrial hyperplasia.Endometrial hyperplasiaN85.0IRCT20140820018866N8Tehran University of Medical Sciences60